

A next-generation finance and accounting firm co-founded by Locust Walk, a global life science investment bank, and Venning Advisors, a full-service CPA firm that originally started in New England in 1978. We deliver specialized financial expertise for biotech pioneers with a people-led, tech-powered, solution that enables our clients to operate, grow and thrive long-term.
Our team includes former Big 4 CPAs, former operational accounting teams as well as Finance, Accounting and Technology experts that support finance transformation initiatives
Our teams understand the unique challenges of pre and post commercial life sciences ventures and have worked within the life sciences industry for numerous decades
We function as an extension of your team, providing the ideal mix of specialized expertise and dedicated support.
Custom-designed financial infrastructure with biotech-specific chart of accounts, processes, and controls.
Strategic financial modeling and burn rate analysis to optimize research funding and clinical development timelines.
Ongoing transaction processing, financial reporting, and compliance management for biotech operations.
Specialized SEC reporting and technical accounting for complex biotech transactions and disclosures.
Comprehensive assessment of financial operations, identifying optimization opportunities specific to biotech company stage and therapeutic focus.
End-to-end preparation for public markets, including financial statement preparation, regulatory compliance, and investor communications.
Preparation of financial documentation, technical memos, and supporting schedules to ensure smooth audit processes.
Implementation of biotech-optimized enterprise resource planning systems that integrate with laboratory and clinical operations.
Implemented cloud ERP for a pre-IPO life sciences company in a compressed timeframe, enabling seamless transition to public company status with robust financial controls.
Redesigned financial close process for a biotech firm, accelerating reporting from 30 to 15 days while improving accuracy and regulatory compliance.
Developed comprehensive whitepapers for biotech investor funding, including specialized accounting for warrants, preferred stock, and convertible notes.
Led end-to-end preparation of financial statements and S-1 Registration for a biotech company entering public markets.
Working across the company lifecycle enables us to grow with our clients providing additional service and sophistication as the company's lifecycle demands.
Establishment of finance and accounting infrastructure to handle ongoing financial and operational accounting including basic cash flow forecasting and financial reporting
•GAAP compliant accounting including technical accounting matters such as preferred stock and share-based accounting. Monthly reporting package including variance analysis, cash flow forecasting and board reporting
SEC reporting support including implementation of accounting tools to support publicly traded companies e.g. lease accounting software, share based compensation software etc. SOX program implementation
•SEC reporting support e.g. 10Q, 10K and Proxy Statements and ongoing SOX walkthroughs and testing to support management's opinion on ICFR as well as external auditors opinion on ICFR
Whether it's a quick question, consultation or something more complex, the Venning Life Sciences Team is ready to help.
Drop us a line today and we look forward to hearing from you.
Email: info@venningls.com
Phone: (617) 440-2535
We manage your finances, you focus on innovation!